Role of mTOR-Chk1 in Enhancing DNA-damaging Therapy

Cell Cycle - United States
doi 10.1080/15384101.2015.1046790
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Endothelial-Cell FAK Targeting Sensitizes Tumours to DNA-damaging Therapy

Nature
Multidisciplinary
2014English

WEE1 Kinase Targeting Combined With DNA-Damaging Cancer Therapy Catalyzes Mitotic Catastrophe

Clinical Cancer Research
Cancer ResearchOncology
2011English

Hyperactive End Joining Repair Mediates Resistance to DNA Damaging Therapy in P53-Deficient Cells

2020English

Combating Resistance to DNA Damaging Agents

Oncoscience
Cancer ResearchOncology
2018English

Activation of ATM by DNA Damaging Agents

2004English

Methods for Detecting DNA Damaging Agents in Humans

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1989English

ATR and DNA-PK/CHK1 Elicit Distinct Responses in Cancer Cells

Cancer Discovery
Oncology
2015English

Important Role of the Nucleotide Excision Repair Pathway in Mycobacterium Smegmatis in Conferring Protection Against Commonly Encountered DNA-damaging Agents

Microbiology
Microbiology
2008English

Induction of Homologous Recombination Following in Utero Exposure to DNA-damaging Agents

DNA Repair
BiochemistryCell BiologyMolecular Biology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy